McClain C J, Barve S, Deaciuc I, Kugelmas M, Hill D
Division of Digestive Diseases and Nutrition, University of Kentucky Medical Center, Lexington 40536-0084, USA.
Semin Liver Dis. 1999;19(2):205-19. doi: 10.1055/s-2007-1007110.
Cytokines are low-molecular-weight mediators of cellular communication produced by multiple cell types in the liver, with the Kupffer cell critically important. Inflammatory cytokines such as tumor necrosis factor, interleukin-1, and interleukin-8, and hepatic acute-phase cytokines such as interleukin-6 play a role in modulating certain metabolic complications in alcoholic liver disease and probably play a role in the liver injury of alcoholic liver disease. Two potential inducers of cytokine production in alcoholic liver disease are endotoxin and reactive oxygen species generated after ethanol metabolism. Cytotoxic cytokines likely induce liver cell death by both necrosis and apoptosis in alcoholic liver disease. Anticytokine therapy has been highly successful in attenuating cell injury/death in a variety of toxin-induced models of liver injury, including alcohol-related liver injury. Anticytokine therapy has been used successfully in humans in disease processes such as Crohn's disease and rheumatoid arthritis. There is an emerging rationale for use of anticytokine therapy in alcoholic liver disease, with the goal of maintaining beneficial effects of cytokines and inhibition of the deleterious effects of these potentially toxic agents.
细胞因子是由肝脏中多种细胞类型产生的低分子量细胞通讯介质,其中库普弗细胞至关重要。肿瘤坏死因子、白细胞介素-1和白细胞介素-8等炎性细胞因子,以及白细胞介素-6等肝脏急性期细胞因子,在调节酒精性肝病的某些代谢并发症中发挥作用,并且可能在酒精性肝病的肝损伤中起作用。酒精性肝病中细胞因子产生的两个潜在诱导因素是内毒素和乙醇代谢后产生的活性氧。在酒精性肝病中,细胞毒性细胞因子可能通过坏死和凋亡诱导肝细胞死亡。在包括酒精相关肝损伤在内的多种毒素诱导的肝损伤模型中,抗细胞因子疗法在减轻细胞损伤/死亡方面非常成功。抗细胞因子疗法已在人类的克罗恩病和类风湿关节炎等疾病过程中成功应用。在酒精性肝病中使用抗细胞因子疗法的理论依据正在出现,其目标是维持细胞因子的有益作用并抑制这些潜在毒性因子的有害作用。